Anti-cancer effects of alpha lipoic acid, cisplatin and paclitaxel combination in the OVCAR-3 ovarian adenocarcinoma cell line

CONCLUSIONS: This study is the first one to investigate the combined treatment of ALA, Cisplatin, Paclitaxel on OVCAR-3. While ALA alone was not effective, combined therapy with ALA, has been found to reduce cell invasion, especially wound healing in the first 24 h, along with tumor cell adhesion.PMID:38578399 | DOI:10.1007/s11033-024-09422-8

Source: Mol Biol Cell - April 5, 2024 Category: Molecular Biology Authors: Hatice Şiyzen Çoban Nazl ı Çil Elif Önder G ülçin Abban Mete Source Type: research